Thus, our findings demonstrate the plasticity of human MCs in a tumor context, show that specific mediators in the melanoma microenvironment dictate their phenotype, and underline the prognostic impact of C3+ MCs in melanoma. The gene discussed is C3; the disease is melanoma.